FIELD: organic chemistry; pharmacology.
SUBSTANCE: invention relates to the use of methyl 5-(4-bromobenzoyl)-4-methoxy-6-(4-fluorophenyl)-2-oxohexahydropyrimidine-4-carboxylate. The use of methyl 5-(4-bromobenzoyl)-4-methoxy-6-(4-fluorophenyl)-2-oxohexahydropyrimidine-4-carboxylate as an agent with anti-inflammatory activity is disclosed.
EFFECT: use of the invention provides effective anti-inflammatory activity.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF METHYL 5-BENZOYL-6-(4-FLUOROPHENYL)-4-METHOXY-2-THIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLATE AS AN ANTI-INFLAMMATORY AGENT | 2022 |
|
RU2786805C1 |
ETHYL 4-(5-BENZOYL-6-(4-(DIETHYLAMINO)PHENYL)-4-HYDROXY-2-THIOXOHEXAHYDROPYRIMIDIN-4-CARBOXAMINO)BENZOATE, EXHIBITING ANALGESIC AND ANTI-INFLAMMATORY ACTION | 2019 |
|
RU2717246C1 |
USE OF 3-METHYL-5-OXO-N-PHENYL-5H-INDENO[1,2-C]PYRIDAZINE-4-CARBOXAMIDE AS AGENT WITH ANTI-INFLAMMATORY ACTIVITY | 2023 |
|
RU2806372C1 |
USE OF 5-BENZOYL-4-HYDROXY-N-(4-IODOPHENYL)-6-(4-CHLOROPHENYL)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXAMIDE AS AGENT WITH ANALGESIC ACTIVITY | 2023 |
|
RU2811249C1 |
USE OF 3,6-DIHYDROXY-6-METHYL-4-(4-FLUOROPHENYL)-4,5,6,7-TETRAHYDRO-2H-INDAZOLE-5-CARBOXAMIDE AS AGENT WITH ANTI-INFLAMMATORY ACTIVITY | 2023 |
|
RU2807019C1 |
N-(4'-METHYLBENZOYL)-3,5-DICHLOROANTHRANILIC ACID BUTYLAMIDE EXHIBITING ANTI-INFLAMMATORY AND ANALGETIC ACTIVITY | 2020 |
|
RU2753655C1 |
USE OF 1,6-(4-BROMOPHENYL)-4-METHYL-N-(2-CHLOROPHENYL)-1,2,3,4-THIOXO-5-TETRAHYDROPYRIMIDINE-5-CARBOXAMIDE AS AN AGENT WITH ANALGESIC ACTIVITY | 2022 |
|
RU2796070C1 |
2-(1,2-DIPHENYL-2-OXOETHYLIDENEHYDRAZINO)-4-(4-METHOXYPHENYL)-4-OXOBUT-2-ENE ACID WITH ANTI-INFLAMMATORY AND ANALGESIC EFFECT | 2006 |
|
RU2348613C2 |
METHYL 4-HYDROXY-4-METHYL-6-PHENYL-2-CYANOACETYLHYDRAZONOCYCLOHEXANE-1-CARBOXYLATE EXHIBITING ANALGESIC ACTIVITY | 2010 |
|
RU2446150C2 |
4-(4-METHYLPHENYL)-4-OXO-2-[3-(ETHOXYCARBONYL-4,5-R,R-THIOPHEN-2-YLAMINO]BUT-2-ENOIC ACID, HAVING ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY | 2008 |
|
RU2389724C1 |
Authors
Dates
2024-01-11—Published
2023-06-06—Filed